Glytec Publishes First COVID-19 Research to Study the ‘Opportunity Window’ for Treating Hospitalized Patients with Diabetes or Hyperglycemia
New Research Published in Diabetes Care Journal Reveals 7x Mortality Risk for Non-ICU Patients with Severe Hyperglycemia After 2-3 Days, Indicating Need to Start Treatment on Admission WALTHAM, MASS. (December 15, 2020) – Glytec, the only provider of insulin management software across the continuum of care, today announced the results of the first COVID-19 research to study the window of...
Read More